WHO urges higher taxes on sugary drinks and alcohol
The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising.
"Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control.
"It's time to act."
The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville.
A 2022 Gallup poll found strong public support for higher taxes on🚨 alcohol,🚨 tobacco,🚨 sugary drinks.Why? Because these products can harm your health & smart taxes help reduce consumption & fund better healthcare. Learn more 👉https://t.co/oyj7y453oB #Tax4Health pic.twitter.com/XAl3ywO9ap— World Health Organization (WHO) (@WHO) July 2, 2025
It said that its tax initiative could raise $US1 trillion ($A1.5 trillion) by 2035 based on evidence from health taxes in countries such as Colombia and South Africa.
The WHO has backed tobacco taxes and price rises for decades and has called for taxes on alcohol and sugary drinks in recent years but this is the first time it has suggested a target price rise for all three products.
WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised.
Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference.
The US is also in the process of withdrawing from the WHO.
As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $US4 today to $US10 by 2035, taking into account inflation, WHO health economist Guillermo Sandoval said.
Nearly 140 countries had already raised tobacco taxes and therefore prices by more than 50 per cent on average between 2012 and 2022, the WHO added.
Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months.
But he added that the agency expected pushback from the industries involved.
The initiative is also backed by Bloomberg Philanthropies, the World Bank and the Organisation for Economic Co-operation and Development (OECD), and involves support for countries who want to take action.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
13 hours ago
- The Advertiser
At-home drug test offers workers more autonomy
A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636
Perth Now
15 hours ago
- Perth Now
At-home drug test offers workers more autonomy
A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636
The Advertiser
4 days ago
- The Advertiser
WHO urges higher taxes on sugary drinks and alcohol
The World Health Organisation is pushing countries to raise the prices of sugary drinks, alcohol and tobacco by 50 per cent over the next 10 years through taxation. The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising. "Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control. "It's time to act." The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville. It said that its tax initiative could raise $US1 trillion ($A1.5 trillion) by 2035 based on evidence from health taxes in countries such as Colombia and South Africa. The WHO has backed tobacco taxes and price rises for decades and has called for taxes on alcohol and sugary drinks in recent years but this is the first time it has suggested a target price rise for all three products. WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised. Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference. The US is also in the process of withdrawing from the WHO. As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $US4 today to $US10 by 2035, taking into account inflation, WHO health economist Guillermo Sandoval said. Nearly 140 countries had already raised tobacco taxes and therefore prices by more than 50 per cent on average between 2012 and 2022, the WHO added. Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months. But he added that the agency expected pushback from the industries involved. The initiative is also backed by Bloomberg Philanthropies, the World Bank and the Organisation for Economic Co-operation and Development (OECD), and involves support for countries who want to take action. The World Health Organisation is pushing countries to raise the prices of sugary drinks, alcohol and tobacco by 50 per cent over the next 10 years through taxation. The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising. "Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control. "It's time to act." The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville. It said that its tax initiative could raise $US1 trillion ($A1.5 trillion) by 2035 based on evidence from health taxes in countries such as Colombia and South Africa. The WHO has backed tobacco taxes and price rises for decades and has called for taxes on alcohol and sugary drinks in recent years but this is the first time it has suggested a target price rise for all three products. WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised. Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference. The US is also in the process of withdrawing from the WHO. As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $US4 today to $US10 by 2035, taking into account inflation, WHO health economist Guillermo Sandoval said. Nearly 140 countries had already raised tobacco taxes and therefore prices by more than 50 per cent on average between 2012 and 2022, the WHO added. Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months. But he added that the agency expected pushback from the industries involved. The initiative is also backed by Bloomberg Philanthropies, the World Bank and the Organisation for Economic Co-operation and Development (OECD), and involves support for countries who want to take action. The World Health Organisation is pushing countries to raise the prices of sugary drinks, alcohol and tobacco by 50 per cent over the next 10 years through taxation. The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising. "Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control. "It's time to act." The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville. It said that its tax initiative could raise $US1 trillion ($A1.5 trillion) by 2035 based on evidence from health taxes in countries such as Colombia and South Africa. The WHO has backed tobacco taxes and price rises for decades and has called for taxes on alcohol and sugary drinks in recent years but this is the first time it has suggested a target price rise for all three products. WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised. Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference. The US is also in the process of withdrawing from the WHO. As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $US4 today to $US10 by 2035, taking into account inflation, WHO health economist Guillermo Sandoval said. Nearly 140 countries had already raised tobacco taxes and therefore prices by more than 50 per cent on average between 2012 and 2022, the WHO added. Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months. But he added that the agency expected pushback from the industries involved. The initiative is also backed by Bloomberg Philanthropies, the World Bank and the Organisation for Economic Co-operation and Development (OECD), and involves support for countries who want to take action. The World Health Organisation is pushing countries to raise the prices of sugary drinks, alcohol and tobacco by 50 per cent over the next 10 years through taxation. The United Nations health agency said the move would help cut consumption of the products, which contribute to diseases like diabetes and some cancers, as well as raising money at a time when development aid is shrinking and public debt rising. "Health taxes are one of the most efficient tools we have," said Jeremy Farrar, WHO assistant-director general of health promotion and disease prevention and control. "It's time to act." The WHO launched the push, which it called "3 by 35" at the UN Finance for Development conference in Seville. It said that its tax initiative could raise $US1 trillion ($A1.5 trillion) by 2035 based on evidence from health taxes in countries such as Colombia and South Africa. The WHO has backed tobacco taxes and price rises for decades and has called for taxes on alcohol and sugary drinks in recent years but this is the first time it has suggested a target price rise for all three products. WHO Director-General Tedros Adhanom Ghebreyesus told the conference that the taxes could help governments "adjust to the new reality" and bolster their own health systems with the money raised. Many low and middle-income countries are coping with cuts to aid spending led by the United States, which is not attending the Seville conference. The US is also in the process of withdrawing from the WHO. As an example, the initiative would mean a government in a middle-income country raising taxes on the product to push the price up from $US4 today to $US10 by 2035, taking into account inflation, WHO health economist Guillermo Sandoval said. Nearly 140 countries had already raised tobacco taxes and therefore prices by more than 50 per cent on average between 2012 and 2022, the WHO added. Sandoval said the WHO was also considering broader taxation recommendations, including on ultra-processed food, after the agency finalises its definition of that type of food in the coming months. But he added that the agency expected pushback from the industries involved. The initiative is also backed by Bloomberg Philanthropies, the World Bank and the Organisation for Economic Co-operation and Development (OECD), and involves support for countries who want to take action.
